What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder cancer? Why do only 20% of advanced bladder cancer cases respond to immunotherapy? These are ...

What if our immune system could cure cancer? This logic seems almost too simple to be true, but it forms the basis of an emerging cancer treatment—immunotherapy. André Veillette, a researcher at the ...

The below is a summary of a story that originally appeared on the Duke Health News website. Immunotherapy has transformed cancer care by helping the immune system recognize and destroy tumors. But new ...

For patients diagnosed with stage 4 cancer, a condition often accompanied by limited treatment options and grim prognoses, immunotherapy offers a new ray of hope. This groundbreaking approach utilizes ...

Immunotherapy for sepsis is effective when doctors tailor the treatment precisely to the patient’s immune system condition. While earlier research showed little benefit of immunotherapy in sepsis, a ...

Immunotherapy Cancer Treatment: Cancer is a common disease these days. Many types of therapies are used to treat it. Meanwhile, immunotherapy has emerged as a new hope in cancer treatment. Instead of ...

Immunotherapy for sepsis is effective when doctors tailor the treatment precisely to the patient's immune system condition. While earlier research showed little benefit of immunotherapy in sepsis, a ...

A person receives subcutaneous immunotherapy as an injection under the skin. This treatment method has shown similar effectiveness to intravenous (IV) infusions that healthcare professionals often use ...

Keytruda is not chemotherapy. It’s a type of treatment called immunotherapy. It works with the body’s immune system, helping T cells fight cancer cells. With immunotherapy, the body’s immune system ...

Researchers identify predictive markers of response to immunotherapy treatment in a study involving data from over 700 patients across six different cohorts. The study has significant relevance, ...

What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder cancer? Why do only 20% of advanced bladder cancer cases respond to immunotherapy? These are ...